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content of 18 free amino acids in 646 urine samples from 
a dietary intervention study. We were able to quantify all 
18 free amino acids in these urine samples, if they were 
present at a level above the LOD. We found our method 
to be reproducible (accuracy and precision were typically 
<10 % for QCL, QCM and QCH) and the relatively high 
sample throughput nature of this method potentially makes 
it a suitable alternative for the analysis of urine samples in 
clinical setting.
Keywords Free amino acids · Human urine · Absolute 
quantification · HILIC-UPLC-qTOF-MS
Introduction
An optimal level of amino acids in the body is important 
for normal homeostasis. They are involved in the regula-
tion of gene expression, cell metabolism and signalling 
and the biosynthesis of hormones (Wu 2009). The detec-
tion and quantification of free amino acids has been rou-
tinely applied for the diagnosis of new born with inborn 
error diseases (Piraud et al. 2011; Giordano et al. 2012). 
More recently, increasing literature has implicated the 
role of free amino acids in a number of diseases such as 
cardiovascular diseases (Batch et al. 2014), insulin resist-
ance and type 2 diabetes (Lu et al. 2013), obesity (Mor-
ris et al. 2012; Wiklund et al. 2014), renal diseases (Batch 
et al. 2014; Kim et al. 2014; Niewczas et al. 2014), hepatic 
disorders (Fitian et al. 2014; Zhou et al. 2014) and a num-
ber of cancer-related disorders (Ma et al. 2014; Zang 
et al. 2014). The increased interest in free amino acids 
has prompted the need for a reliable and high-throughput 
simultaneous quantification of free amino acids in biologi-
cal fluids.
Abstract An ultra-performance liquid chromatography 
quadrupole time of flight mass spectrometry (UPLC-qTOF-
MS) method using hydrophilic interaction liquid chroma-
tography was developed and validated for simultaneous 
quantification of 18 free amino acids in urine with a total 
acquisition time including the column re-equilibration of 
less than 18 min per sample. This method involves sim-
ple sample preparation steps which consisted of 15 times 
dilution with acetonitrile to give a final composition of 
25 % aqueous and 75 % acetonitrile without the need of 
any derivatization. The dynamic range for our calibration 
curve is approximately two orders of magnitude (120-fold 
from the lowest calibration curve point) with good linear-
ity (r2 ≥ 0.995 for all amino acids). Good separation of 
all amino acids as well as good intra- and inter-day accu-
racy (<15 %) and precision (<15 %) were observed using 
three quality control samples at a concentration of low, 
medium and high range of the calibration curve. The limits 
of detection (LOD) and lower limit of quantification of our 
method were ranging from approximately 1–300 nM and 
0.01–0.5 µM, respectively. The stability of amino acids in 
the prepared urine samples was found to be stable for 72 h 
at 4 °C, after one freeze thaw cycle and for up to 4 weeks 
at −80 °C. We have applied this method to quantify the 
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Quantitative analysis of amino acids by traditional 
reverse-phase high-performance liquid chromatogra-
phy (HPLC) is hampered by both the lack of a significant 
chromophore in many of their structures, which negates the 
use of UV detection, and by their high polarity, which leads 
to poor retention on reverse-phase columns. Quantification 
of physiological free amino acids in biofluids is often per-
formed by ion-exchange chromatography with post-column 
derivatization using ninhydrin as chromophore (Moore et al. 
1958; Spackman and Moore 1958; Waterval et al. 2009). 
However, this method typically involves time-consuming 
derivatization processes and often requires long chromato-
graphic run times of about 2–3 h per sample, and therefore 
is not suitable for high throughput (Kaspar et al. 2009b). The 
method also suffers from lack of analyte specificity due to 
interference by co-eluting compounds and thus limits accu-
rate quantitation for some amino acids such as methionine 
and phenylalanine (Dietzen et al. 2008). Moreover, this tech-
nique needs to be performed using dedicated equipment to 
ensure excellence in reproducibility (Waterval et al. 2009).
A variety of methods have been developed for profil-
ing of amino acids in the body fluids. This includes meth-
ods such as capillary electrophoresis (Hirayama and Soga 
2012; Lorenzo et al. 2013; Poinsot et al. 2014), gas chro-
matography–mass spectrometry (GC–MS) (Namera et al. 
2002; Kaspar et al. 2009a; Kvitvang et al. 2011), liquid 
chromatography–mass spectrometry (LC–MS) (Chen 
et al. 2014; Le et al. 2014) and more sensitive and specific 
LC–MS/MS (Waterval et al. 2009; Giordano et al. 2012). 
In addition, several commercially available derivatization 
reagents (Fernández-Fı ғgares et al. 2004; Armenta et al. 
2009; Held et al. 2011; Salazar et al. 2012) and the use of 
volatile ion-pairing agents (Qu et al. 2002; Armstrong et al. 
2007; Piraud et al. 2011) have also been applied to quan-
tify the content of amino acids in biological samples with 
some success. Nonetheless, these methods are potentially 
limited by the instability in the derivatization process (Gu 
et al. 2007). Hydrophilic interaction liquid chromatography 
(HILIC) improves the retention of polar compounds and 
offers the potential for a successful method for the analy-
sis of amino acids in complex biological matrices without 
the need of derivatization or ion-pairing agents. Indeed, the 
use of HILIC coupled with MS detection for the analysis 
of amino acids, in plant and cellular extracts, as well as in 
biological fluids such as serum, plasma and urine has been 
successfully applied (Langrock et al. 2006; Paglia et al. 
2012; Yuan et al. 2012; Buiarelli et al. 2013; Guo et al. 
2013; Zhou et al. 2013).
The guidance on bioanalytical method validation pro-
vided by the Food and Drug Administration (FDA) requires 
the demonstration of the reproducibility of a method in 
terms of its accuracy, precision and stability, when any 
modification to an existing method is made (US Food and 
Drug Administration 2001). In this study, we apply the 
same HILIC-based chromatographic method previously 
developed for the analysis of free amino acids in plant 
extracts as described by Guo et al. Instead of using a triple 
quadrupole LC–MS/MS method with targeted detection by 
multiple reaction monitoring (MRM) for quantitative anal-
ysis of these free amino acids, we apply a full scan LC–MS 
method using a qTOF. Here, we present and describe the 
development and validation of a UPLC-qTOF-MS method 
using HILIC conditions for simultaneous absolute quantifi-
cation of free amino acids in human urine samples. We also 




L-Phenylalanine (Phe), L-tryptophan (Trp), L-leucine (Leu), 
L-isoleucine (Ile), L-methionine (Met), L-valine (Val), 
Fig. 1  Effect of modification of 
the Quadrupole RF settings for 
Ala and Gly
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L-alanine (Ala), L-threonine (Thr), L-glycine (Gly), L-serine 
(Ser), L-asparagine (Asn), L-aspartic acid (Asp), L-cysteine 
(Cys), L-arginine (Arg), L-histidine (Hit), L-lysine (Lys) 
were purchased from Sigma-Aldrich (Gillingham, Dor-
set, UK). L-Proline (Pro), L-glutamic acid (Glu), L-glu-
tamine (Gln) and L-tyrosine (Tyr) were purchased from 
Fisher Scientific (Loughborough, UK). Their correspond-
ing labelled amino acids, with the atom % deuteration 
shown in brackets, were purchased from Sigma-Aldrich for 
L-Phenyl-d5-alanine (Phe-d5, 98 %), L-tryptophan-indo-d5 
(Trp-d5, 97 %), L-methionine-methyl-d3 (Met-d3, 98 %), 
L-valine-d8 (Val-d8, 98 %), L-proline-2,5,5-d3 (Pro-d3, 
Fig. 2  Typical UPLC accurate 
mass chromatograms of the 
ions extracted for non-labelled 
and deuterated amino acids 
in a standard mix. Note For 
L-glycine-d5, we monitored 
Gly-d2 and for L-asparagine-d8, 
we monitored Asn-d3 as the 
remainders of the deuterium are 
exchangeable
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97 %), L-alanine-3,3,3-d3 (Ala-d3, 99 %), L-glycine-d5 
(Gly-d5, 98 %), L-leucine-5,5,5-d3 (Leu-d3, 99 %), L-glu-
tamic acid-2,3,3,4,4-d5 (Glu-d5, 98 %), L-asparagine-
d8 (Asn-d8, 97 %), L-cysteine-2,3,3-d3 (Cys-d3, 98 %), 
L-histidine-(alpha-d, imidaxole,2,5-d2) hydrochloric 
monohydrated (Hit-d3, 97 %), L-tyrosine-phenyl-d4 (Tyr-
d4, 98 %) and L-arginine-2,3,3,4,4,5,5-d7 hydrochloride 
(Arg-d7, 98 %); and CND Isotopes (QMX, Thaxted, UK) 
for L-isoleucine-2-d1 (Ile-d1, 98.9 %), L-threonine-2,3-d2 
(Thr-d2, 98.8 %), L-serine-2,3,3-d3 (Ser-d3, 99.1 %) and 
L-glutamine-2,3,3,4,4-d5 (Gln-d5, 98.8 %). All reference 
amino acids had a purity >99 %. The HPLC grade acetoni-
trile, formic acid, and water were purchased from Sigma-
Aldrich. Ammonium formate was purchased from Fisher 
Fig. 3  Typical UPLC accurate 
mass chromatograms of the 
ions extracted for non-labelled 
and deuterated amino acids in a 
urine sample
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Scientific. All chemicals and reagents were of appropriate 
analytical grades.
Instrumentation and experimental conditions
The analyses of urine samples were performed on a 
Waters Synapt G2 UPLC-qTOF-MS (Waters Corporation, 
Wilmslow, UK) system consisting of a Waters binary sol-
vent delivery system and an autosampler operating Mass-
lynx acquisition software (Synapt, version 4.1 Waters, 
USA). The electrospray ionisation (ESI) used a capil-
lary voltage of 0.8 kV for positive mode; cone voltage 
15 V; source temperature 150 °C; desolvation temperature 
350 °C; cone gas flow 50 L/h and desolvation gas flow 
800 L/h. The scan range was m/z 50–600 Da and the mass 
spectrometer resolution was 10,000, enabling mass accu-
racy within 2 mDa. The Leu-enkephalin (m/z 556.2771) 
was used as the lock mass solution for accurate mass 
calibration during long analytical sequences to counteract 
the potential effect of calibration drift during the long ana-
lytical run time.
Five microliters of each sample was injected onto a 
Waters ACQUITY UPLC BEH amide column (1.7 µm, 
2.1 mm × 100 mm) with a VanGuard HSS T3 (1.8 µM) 
pre-column. The HILIC chromatographic condition was 
based on Guo et al. (2013) with modifications to the 
gradient, aiming to improve the sensitivity and specific-
ity of analytes with longer retention time. The mobile 
phases consisted of an aqueous phase (A), containing 
water, 10 mM ammonium formate, and 0.15 % formic 
acid and an organic phase (B), containing acetonitrile, 
1 mM ammonium formate, and 0.15 % formic acid. 
The flow rate was fixed at 0.4 mL/min with a gradient 
elution that started at 15 % of A and increased linearly 
to 20 % in 6 min; 20–45 % A, 6–10 min; 45–55 % A, 
10–12.5 min; and finally 55–95 % in 0.1 min. The LC 
flow was diverted to waste at 12.6 min and continued 
for 1.4 min of each run before the column was re-equil-
ibrated in the initial condition for 2.9 min, in an attempt 
to flush highly polar urine components off the column 
and away from the mass spectrometer source. The col-
umn was maintained at 35 °C and the samples were 
maintained at a temperature of 4 °C prior to injection. A 
strong (20 % acetonitrile:80 % water) and weak (80 % 
acetonitrile:20 %water) needle wash was performed 
between each injection.
Preparation of standard solutions and calibration 
standards
All stock solutions of labelled and non-labelled amino acids 
were prepared in water at 5 and 20 mM, respectively, except 
Tyr and Tyr-d4, both at 2 mM due to its low solubility. These 
non-labelled stock solutions were used to prepare calibration 
standards in diluent and pooled urine sample. Calibration 
ranges were determined based on the concentrations observed 
in the pooled QC urine sample. A final seven-point calibra-
tion standards at 0.1, 1.0, 2.0, 4.0, 6.0, 8.0, and 12.0 µM 
were prepared for Phe, Trp, Leu, Val and Thr. The calibration 
curves were at a factor of 0.1 for each of the above ranges for 
Arg and Glu; 0.2 for Met and Pro; 0.5 for Ile, Ser, Asn, and 
Lys; 1.5 for Gln; 2.5 for Tyr; 3 for Gly and Hit; and 5 for Ala. 
Cys and Asp were not added in the final calibration curve as 
neither was detected in the pooled QC sample. Moreover, Cys 
was found to be unstable and formed the dimer, cystine in the 
solution within 2 weeks and was hence not suitable for anal-
ysis of large-scale studies that involve long analytical runs 
whilst Asp gave a broad chromatographic peak.
A fixed amount of labelled amino acids were prepared 
at the same concentration of the third lowest point on the 
calibration curve for each amino acid, with a minimum 
Fig. 4  Extracted ion chromatograms that show interference from 
other closely eluting compounds in the urine sample for molecular 
ions of Tyr (panel a) and Val (panel b), and their corresponding frag-
ment ion that are free from interference
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concentration of 1 µM to ensure a good signal to noise ratio 
(S:N). All stock solutions were prepared and aliquoted and 
stored in glass vials at −20 °C until analyses.
Preparation of human urine and quality control 
samples
All urine samples were deproteinized by the addition of 
acetonitrile (100 µL of urine: 1081.1 µL of acetonitrile) 
and centrifugation at 1800g for 10 min. The supernatant 
(708.7 µL) was added to 36 µL of labelled stock solution 
and 155.3 µL of water to give final solution of 900 µL 
with composition of 75 % acetonitrile: 25 % aqueous and 
a final dilution of 15 times for the urine samples and 25 
times for labelled stock solutions. A QC sample was pre-
pared using an equal part of all 646 urine samples from a 
dietary intervention study (see amino acid quantitation in 
human urine samples later for the description of this study). 
A volume of 6 mL of the QC sample was used to prepare 
each of the QC-low (QCL), QC-medium (QCM) and QC-
high (QCH) samples, by spiking in a known concentration 
of each amino acid at 3, 30 and 75 times the lowest concen-
tration on the calibration curve and they therefore represent 
a concentration in the low, medium and high range, respec-
tively, of the calibration curve for each amino acid under 
investigation.
Data analysis
The chromatographic data were processed using QuanLynx 
(v 4.1, Waters, USA). Automatic generation of extracted 
ion chromatograms (EICs) was achieved by an 8 mDa 
chromatogram mass window on the expected m/z and mass 
resolution of 10,000 for both the analytes and their deuter-
ated analogues. For amino acids with incomplete baseline 
separation of chromatographic peaks, the integration was 
manually adjusted to ensure the non-labelled standard and 
labelled internal standard peaks were processed in a uni-
form manner to ensure consistent results.
The calibration curves were constructed by calculat-
ing the chromatographic peak area ratio of the analyte and 
internal standard (IS) for each amino acid and at each con-
centration level. The ratio was calculated using (IS concen-
tration ÷ IS peak area) × analyte peak area. Linear regres-
sion analyses were performed using six replicates of the 
calibration curve data. The correlation coefficient (r) was 
Table 1  The matrix effects, coefficient of determination, limits of detection (LODs), lower limits of quantification (LLOQ) and upper limits of 
quantification (ULOQ) of each amino acid
LOD for Asp and Cys are 250 and 400 nM (fresh solution), respectively. No other data were available as neither was detected in the biological 
matrix
LLOQ lower limit of quantification. This corresponds to the lowest point in the calibration curve
ULOQ upper limit of quantification. This corresponds to the highest point in the calibration curve
* Results based on four replicates after re-optimising the RF setting for low mass molecules
Analyte Matrix effect Coefficient of determination (r2) LOD (nM) LLOQ (µM) ULOQ (µM)
Slope ratio Ratio QCM Ratio QCH
Phe 0.98 0.95 0.97 1.000 12.1 0.10 12.0
Trp 0.99 0.96 0.99 1.000 4.4 0.10 12.0
Leu 0.91 0.91 0.95 0.999 2.7 0.10 12.0
Ile 0.94 0.91 0.92 0.995 1.3 0.05 6.0
Met 0.97 0.94 0.95 0.997 0.7 0.02 2.4
Val 0.97 0.96 0.97 0.999 44.1 0.10 12.0
Pro 0.92 0.90 0.91 0.996 18.8 0.02 2.4
Tyr 1.05 0.95 1.05 0.997 21.3 0.25 30.0
Ala* 0.93 0.93 0.94 1.000 294.1 0.50 60.0
Thr 0.99 1.10 1.08 0.999 12.3 0.10 12.0
Gly* 0.95 0.93 0.91 0.999 145.2 0.30 36.0
Glu 0.95 0.91 0.91 0.995 6.4 0.01 1.2
Gln 1.00 1.03 1.04 1.000 23.9 0.15 18.0
Ser 0.99 0.97 0.98 0.996 23.4 0.05 6.0
Asn 1.03 0.98 0.99 0.998 20.8 0.05 6.0
Hit 0.98 1.02 0.99 0.999 10.4 0.30 36.0
Arg 1.03 1.00 1.10 0.999 5.9 0.01 1.2
Lys 1.03 1.01 1.02 0.996 8.3 0.05 6.0
225Development and validation of an ultra-performance liquid chromatography quadrupole time of…
1 3
calculated for each amino acid and considered as accept-
able when the coefficient of determination r2 ≥ 0.99. The 
limit of detection (LOD) for each amino acid was deter-
mined using six replicates and was set at the chromato-
graphic peak area compared to the blank sample with 
S:N > 3. The lower limit of quantification (LLOQ) was set 
at the lowest concentration of the calibration curve.
The matrix effect was determined by comparing the 
slope of the calibration curves, prepared in biological 
matrix and in diluents, and the matrix effect was consid-
ered negligible for slope ratios in the range 0.9–1.1 (Jia 
et al. 2011; Chen et al. 2012; Guo et al. 2013). The slope 
ratio = 1 implies no matrix effect of the mass spectrom-
eter whilst ratio >1 indicates ionisation enhancement and 
<1 indicates suppression. The ratio of QCM and QCH was 
also measured against each calibration curve and similar 
acceptance criteria were applied. Carry-over was evaluated 
using both the highest point of the calibration curves and 
QCH, followed by diluents in three replicates.
Intra- and inter-day accuracy and precision were evalu-
ated using replicates of each QCL, QCM and QCH on 
the same day and over a 4-week period. Accuracy was 
determined by calculating the percentage of deviation 
of the measured amount by the actual added amount, % 
accuracy = [mean measured amount − mean nominal 
amount ÷ mean nominal amount] × 100; and precision 
was calculated by the relative standard deviation (RSD) 
for each amino acid,  % precision = [standard deviation of 
mean measured amount ÷ mean measured amount] × 100. 
Precision and accuracy were considered acceptable when 
values were <20 % for QCL and <15 % for QCM and QCH 
for at least two-thirds of the replicates, based on the cri-
teria outlined on the FDA guidelines (US Food and Drug 
Administration 2001). In addition, the stability of the amino 
acids in the urine samples was evaluated using a pooled QC 
urine sample under four different storage conditions: (1) 
freshly prepared; (2) short-term stability in 4 °C for 72 h; 
(3) 4 weeks storage at −80 °C; and (4) one freeze–thaw 
cycle after storage at −80 °C.
Amino acid analysis by AccQ-Tag
Seventeen urine samples were analysed using HPLC sys-
tem with a pre-column fluorescent derivatization reagent, 
AccQ-Tag, and were prepared following manufacturer 
standard protocols (Cohen and Michaud 1993). Data for 
all free amino acids were compared using Bland–Alt-
man analysis where the mean difference between the two 
methods (UPLC-qTOF-MS and Accq-Tag) was obtained 
(Bland and Altman 1986). The mean deviation (%) of all 
Table 2  Intra- and inter-day accuracy and precision
Analyte Intra-day reproducibility (over a single day) Inter-day reproducibility (over 4 weeks)

























Phe 10.0 11.6 1.5 2.0 −0.7 1.2 4.7 8.1 1.9 2.1 1.2 −0.8
Trp 9.5 9.3 3.9 1.5 2.4 3.6 6.4 7.6 3.6 2.3 3.0 2.7
Leu 1.7 2.6 −0.3 0.4 −3.5 1.9 0.9 2.5 2.2 4.8 −1.2 4.2
Ile 11.0 6.5 8.7 3.5 7.8 4.3 7.2 7.1 8.4 6.5 3.4 8.1
Met 17.4 12.4 1.2 6.4 2.5 6.6 12.1 7.6 1.2 5.0 −3.8 5.0
Val 5.6 3.6 10.2 3.0 5.5 4.2 7.9 3.2 8.2 3.0 4.6 3.3
Pro 7.5 9.1 6.9 5.3 7.7 1.3 7.0 8.1 0.4 8.8 1.9 6.6
Tyr 4.0 6.5 6.9 7.2 2.1 2.6 5.7 10.3 2.8 7.3 −4.7 7.9
Ala 0.3 2.6 3.2 1.0 0.2 2.2 −1.8 2.6 1.9 2.2 0.6 1.8
Thr −7.7 12.8 −3.2 4.4 −1.8 4.5 0.5 10.5 1.9 5.1 −2.0 6.0
Gly 3.2 6.6 1.7 7.0 −3.2 10.4 2.4 5.5 4.1 6.5 −0.9 6.6
Glu 11.3 5.3 0.0 9.7 1.1 14.0 13.0 8.8 5.4 9.0 −0.3 9.3
Gln 7.8 2.3 6.6 9.3 −0.6 4.0 5.0 2.7 4.5 5.7 0.5 3.4
Ser 12.4 6.1 6.4 8.1 6.8 11.7 11.0 9.8 5.4 6.8 1.9 8.0
Asn 5.0 3.2 5.3 8.1 7.8 4.2 5.7 9.8 8.8 10.7 6.7 5.7
Hit 8.6 4.4 3.4 2.5 0.8 2.7 6.4 3.7 2.7 2.9 0.8 2.2
Arg 4.5 5.8 4.5 4.9 2.1 3.8 7.2 6.9 3.6 4.2 −0.7 4.6










Table 3  Stability of amino acids in the unspiked QC urine sample under different storage conditions
* The actual urinary concentration for each amino acid is 15 times of the reported measured concentration due to the 15-fold dilution of the urine sample during sample preparation
Analyte Overall (n = 19) Freshly prepared (n = 4) Stored in 4 °C for up to 72 h (n = 9) Stored in −80 °C for 4 weeks 
(n = 5)
One freeze thaw cycle (n = 5)




















Phe 2.17 2.3 2.13 0.9 2.17 2.5 2.18 3.1 2.17 1.2
Trp 3.70 2.1 3.76 1.1 3.74 1.8 3.63 1.6 3.70 2.1
Leu 1.53 5.2 1.50 1.4 1.55 4.1 1.43 2.1 1.58 3.6
Ile 0.65 8.2 0.66 9.2 0.67 5.9 0.58 2.8 0.68 4.7
Met 0.23 7.5 0.21 4.2 0.23 8.5 0.23 8.4 0.24 5.3
Val 1.55 5.8 1.53 4.9 1.58 5.3 1.49 2.5 1.55 7.7
Pro 0.29 5.9 0.31 4.1 0.30 5.3 0.28 6.5 0.28 4.0
Tyr 3.49 6.8 3.64 8.7 3.61 6.8 3.45 6.1 3.33 5.2
Ala 7.05 2.5 6.98 1.9 6.98 1.9 7.04 1.3 7.12 3.8
Thr 2.87 11.8 3.29 10.7 3.13 8.7 2.56 5.5 2.71 6.9
Gly 17.34 6.8 17.08 11.3 17.83 2.4 18.00 3.3 16.88 4.2
Glu 0.08 12.4 0.07 8.1 0.08 12.6 0.08 13.8 0.08 12.1
Gln 5.82 4.1 5.68 2.8 5.68 2.8 5.77 1.4 6.11 3.7
Ser 2.13 8.8 2.13 10.1 2.13 10.1 2.18 6.6 2.09 9.5
Asn 1.00 8.9 0.96 7.8 0.96 7.8 0.97 4.9 1.11 3.8
Hit 3.91 2.5 3.94 2.2 3.94 2.2 3.84 1.6 3.94 3.0
Arg 0.05 11.0 0.05 7.3 0.05 7.3 0.05 6.2 0.06 12.4
Lys 0.17 13.4 0.15 8.0 0.15 8.0 0.17 6.8 0.20 6.3
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measurements and mean difference in both absolute meas-
ured value (µM) and adjusted for urinary creatinine (µM/
mM) as measured by Jaffe method were obtained. The 
relative total technical error of measurement (TEM) as 





 × 100 %, where d 
is the difference between measurements, N is the number of 
measurements made on each occasion and x¯ is the mean of 
all samples values (Ulijaszek and Kerr 1999).
Amino acids quantitation in human urine samples
Human urine samples were obtained from the OmniHeart 
Study. Details of the study design, aims and main out-
comes of the study have been published (Appel et al. 2005; 
Carey et al. 2005; Furtado et al. 2008). Briefly, OmniHeart 
Study is a cross-over, three-period, randomised feeding 
trial where individuals were fed with three different healthy 
diets, each for 6 weeks. Urine samples were collected prior 
to the start of any dietary intervention and at the end of each 
6-week intervention (N = 646 urine samples). Urine sam-
ples were transferred on dry ice to our central laboratory 
in Chatham, Kent for storage until analysis. All participants 
provided formal written consent and ethics approval was 
obtained from Johns Hopkins University medical institu-
tions and Brigham Women’s Hospital.
We applied our method to quantify these 18 free amino 
acids using a random subset of human urine samples from 
the OmniHeart Study (N = 87) to evaluate the feasibility of 
this method on real biological matrix before applying the 
method on the remaining samples. This is important since 
our method had not previously been applied to human urine 
samples.
Results and discussion
Method development and optimization
This study aimed at the development and validation of 
a UPLC-qTOF-MS method using HILIC conditions for 
absolute quantitation of free amino acids in human urine 
samples. We assessed the optimal urine sample preparation 
Table 4  Accuracy, precision and dynamic range for the quantification of amino acids in NIST certified standards (five replicates)
a The NIST Standard at 5 µM is above the range of the standard calibration curve for Met, Pro, Glu and Arg. These compounds were also meas-
ured against NIST Standard at 0.025 µM. The mean, standard deviation, precision and accuracy were Met (0.025 µM, 0.0016, 6.4 and 1.7 %), 
Pro (0.025 µM, 0.0014, 5.7 and 0.9 %), Glu (0.028 µM, 0.0011, 6.4 and 12.3 %) and Arg (0.027 µM, 0.0033, 12.1 and 9.0 %)
b A higher NIST Standard at 50 µM was also measured for Ala due to its higher calibration range. The mean, standard deviation, precision and 
accuracy for Ala were 52 µM, 0.4614, 0.9 and 4.0 %
c Standard calibration curves were created with a minimum concentration of 0.625 nM and a maximum concentration of 150 µM. The LLOQ 
was taken as the concentration of the standard compound that gave a S:N > 5 and the ULOQ was the highest concentration of the calibration 
curve






















Phe 0.76 0.02 2.1 −5.2 5.09 0.07 1.4 1.7 0.025 30.0 0.998
Leu 0.72 0.02 3.2 −9.6 5.04 0.13 2.6 0.7 0.0125 30.0 0.997
Ile 0.76 0.02 2.2 −4.6 4.77 0.21 4.4 −4.6 0.0125 30.0 0.995
Meta 0.77 0.02 2.2 −4.0 5.01 0.16 3.3 0.2 0.00625 15.0 0.999
Val 0.8 0.01 1.4 −0.6 5.12 0.03 0.6 2.4 0.0025 6.0 0.993
Proa 0.77 0.01 0.8 −3.6 5.11 0.12 2.3 2.2 0.1 30.0 0.996
Tyr 0.77 0.03 3.9 −3.7 4.84 0.13 2.6 −3.2 0.02 6.0 0.998
Alab 0.77 0.02 2.7 −3.5 4.61 0.06 1.2 −7.9 0.0625 75.0 0.996
Thr 0.78 0.01 1.3 −2.4 4.95 0.15 3.1 −1.0 0.5 150.0 0.997
Gly 0.8 0.03 3.2 −0.5 5.07 0.14 2.9 1.4 0.05 30.0 0.999
Glub 0.76 0.02 2.3 −5.6 4.61 0.11 2.3 −7.8 0.3 90.0 0.997
Ser 0.81 0.03 3.1 1.4 4.95 0.10 2.1 −1.0 0.01 3.0 0.997
Hit 0.74 0.01 1.4 −7.0 4.54 0.11 2.3 −9.1 0.075 45.0 0.997
Arga 0.8 0.02 2.0 −0.3 5.25 0.09 1.8 5.0 0.05 15.0 0.999
Lys 0.78 0.02 2.8 −1.9 4.91 0.10 2.1 −1.8 0.05 15.0 0.999
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process by adding fixed concentration of labelled com-
pounds and diluting the pooled QC sample with water by a 
factor of 5, 10, 15, 20, 25, 50, 75 and 100 times but main-
taining the final composition of 75 % acetonitrile:25 % 
aqueous. For most analytes, the results obtained were simi-
lar in the 15, 20 and 25 dilutions, with a maximum peak 
area for non-labelled compound in the 15-fold dilution, 
suggesting a degree of ion suppression at lower dilutions. 
Some compounds (Met, Val, Gly, Glu, Ser, Asn, Lys) were 
not detected in the QC pooled samples at dilutions greater 
than 15, suggesting that the absolute concentrations in 
these dilutions were approaching the LOD. All urine sam-
ples were, therefore, subsequently prepared using a 15-fold 
dilution.
We found the quadrupole RF settings were not optimal 
and this restricted the passage of low molecular mass ions 
(<100). We improved it by optimising the RF setting of 
the qTOF instrument, adjusting the RF offset settings to: 
source, 100 V; trap 140 V; IMS 50 V; and transfer 100 V. 
This resulted in increases in signal for Gly and Ala of 
approximately 50- and 10-fold, respectively (Fig. 1). The 
signal for other amino acids was not affected.
Typical accurate mass chromatograms from a standard 
mix solution are shown in Fig. 2. All amino acids show sat-
isfactory peak shape and minimal peak overlapping. The 
accurate mass chromatogram of urine samples is clearly 
more complex than the standard mix solution (Fig. 3). For 
all amino acids except Val and Tyr, we used the accurate 
mass for protonated molecular ion, [M + H]+ and the 
retention time to correctly identify and quantify the ana-
lytes. For Val and Tyr, the [M + H]+ ions show closely 
co-eluting compounds in the urine sample which prevent 
accurate quantification of Val and Tyr using [M + H]+. 
However, we were able to use fragment ions at m/z 72.081 
([M + H-HCO2H]
+) and 165.056 ([M + H-NH3]
+), 
respectively, to quantify the concentration of these two 
amino acids (Fig. 4). In both cases, the fragment ions 
are considerably less intense than the [M + H]+ ions, at 
approximately 4 and 15 times for Val and Tyr, respectively. 
This reduces the potential sensitivity and specificity of the 
method for these two compounds. Nevertheless, the com-
bination of the detection of the correct fragment ion at the 
correct retention time provided adequate confidence on the 
use of the fragment ions. We recognise that the use of frag-
ment ions is less satisfactory than the use of [M + H]+ ions 
but this was not possible due to interference from the urine 
samples. 
Selectivity, linearity, matrix effects and reproducibility 
of UPLC-qTOF-MS approach
Table 1 shows the results of the matrix effects, linearity, 
LOD, LLOQ and upper LOQ (ULOQ) of the method. 
The slope ratios of the calibration curves, QCM and 
QCH for all 18 analytes were between 0.9 and 1.1, indi-
cating minimum matrix effects based on a 15-fold dilu-
tion. Since both types of calibration curves generated 
similar results, we have subsequently decided to pre-
pare all calibration curves using diluent. The effects of 
carry-over were evaluated using the highest point of the 
calibration curve and QCH. No peak corresponding to 
labelled analytes was detected in the blank diluent (data 
not shown). The linearity, r2, was ≥0.995 for all amino 
acids and the dynamic range of the method, based on the 
calibration curve, was typically at two orders of magni-
tude (120-fold of the LLOQ). The intra- and inter-day 
accuracy and precision based on the QCL, QCM and 
QCH are shown in Table 2. The intra-day accuracy and 
precision were determined using four replicates of QCL, 
QCM and QCH in a single run. The inter-day analysis 
was performed using ten replicates over 4 weeks. We 
found our method fully complied with the FDA guide-
lines and with accuracy and precision of typically <15 % 
for QCL, QCM and QCH. The stability of the amino 
acids in urine samples was evaluated under four differ-
ent conditions (Table 3). The urine samples remained 
stable for up to 72 h at fridge temperature (4 °C); for 
4 weeks when stored at −80 °C; and when subjected to 
one freeze thaw cycle. These results were comparable 
to those from freshly prepared urine samples. The pre-
cision of all 19 replicates based on pooled QC samples 
for all four different conditions was generally <15 % for 
all amino acids. These results together with those from 
Table 2 thus show good reproducibility and providing 
confidence in our method.
We found our method generally offered similar or bet-
ter sensitivity than that obtained by other triple quadru-
pole methods using MRM detection and HILIC chroma-
tography. The use of MRM enables the selection of single 
precursor and product ion for each compound of inter-
est and therefore provides high specificity and selectiv-
ity for the quantification of each analyte. Specificity in 
our UPLC-qTOF-MS method is provided by the genera-
tion of accurate mass chromatograms and generally gave 
considerably lower LODs, between 20 and 50 times, for 
Arg, Glu, Lys, Asn, Hit, Ser and Thr but lower sensitiv-
ity for Pro and Ala (Guo et al. 2013; Yao et al. 2013). 
Our method also provided lower detection limits than 
other reported methods using time of flight mass analys-
ers (Paglia et al. 2012). However, some recent advances in 
MS have applied the orbitrap mass spectrometer, operat-
ing in full scan mode (Nemkov et al. 2015), resulting in 
considerably better sensitivity. Domingues et al. applied 
triple quadrupole MRM method showing better sensitiv-
ity than our method, with LLOQ in the values of tens of 
nanomoles (Domingues et al. 2015). Others make use of 
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derivatization agents (Armenta et al. 2009; Salazar et al. 
2012) and ion-pairing agents (Gu et al. 2007; Le et al. 
2014) for targeted analysis of polar metabolites includ-
ing amino acids. Although these methods show better 
sensitivity than our method, the need of derivatization 
could introduce potential errors. Moreover, based on our 
previous experience, our initial assessment using an ion-
pairing agent, perfluorocarboxylic acid, together with a 
reverse-phase UPLC-MS method for quantification of 
free amino acids has generated numerous challenges. We 
found the accumulation of perfluorocarboxylic acid in 
the instrument contaminated both the positive and nega-
tive ion electrospray which affects the sensitivity of the 
MS for this analysis and for analyses performed by other 
users on the same instrument. The accumulation of per-
fluorooctanoic acid in the column also affected the prop-
erties of column and led to instability of retention time 
for several amino acids (data not shown). These limit the 
application of the method and are particularly not suitable 
for use in our institution where the instrument is used by 
other users for different types of analyses on a daily basis. 
As a consequence, we applied a HILIC method that does 
not require any derivatization or ion-pairing agents. Our 
method using the qTOF at high resolution enables accu-
rate mass scanning across m/z 50–600. This enables tar-
geted analysis, of all 18 free amino acids by spiking in 
deuterated internal standards, and untargeted analysis of 
other compounds present in the analytical samples in the 
same analytical run. We considered that the latter feature 
offers a significant advantage over some of the existing 
methods as these data may be further analysed to extract 
additional useful information. The data on untargeted 
analysis are beyond the scope of this paper and therefore 
will not be discussed further.
The throughput of our method is good, 18 min per 
sample including column re-equilibration time. Our 
throughput may not be as high compared to some of the 
methods discussed here, typically with a total acquisi-
tion of <10 min (Buiarelli et al. 2013; Nemkov et al. 
2015), whilst Nemkov et al. by far is the quickest 
method with a 3-min acquisition time (Nemkov et al. 
2015).
Table 5  Application of UPLC-qTOF-MS for the analysis of 87 human urine samples acquired in one batch
* The actual urinary concentration for each amino acid is 15 times of the reported measured concentration due to the 15-fold dilution of the urine 
sample during sample preparation




















Phe 2.52 1.7 3.9 5.29 2.3 2.0 9.60 −0.8 1.3
Trp 4.11 3.8 4.3 6.87 3.1 2.4 11.53 3.3 2.2
Leu 1.82 0.5 2.6 4.68 3.8 5.6 9.04 0.3 4.7
Ile 0.81 3.8 2.9 2.30 7.8 8.1 4.40 0.3 9.0
Met 0.32 10.4 3.7 0.84 1.6 4.1 1.65 −4.5 4.2
Val 1.99 9.3 2.5 4.82 6.8 2.4 9.38 4.1 2.8
Pro 0.36 5.0 3.7 0.84 −4.7 4.2 1.74 −2.4 3.8
Tyr 4.38 5.6 12.7 10.85 −0.4 4.6 20.07 −9.4 5.4
Ala 8.33 −2.9 2.5 22.35 1.2 2.7 45.00 0.9 1.7
Thr 3.02 2.9 6.9 5.83 3.5 5.1 9.79 −3.3 4.8
Gly 18.60 1.4 4.4 27.88 5.5 6.7 40.15 0.5 3.2
Glu 0.13 16.1 7.9 0.41 9.4 6.1 0.82 −1.0 6.2
Gln 6.66 4.3 3.0 10.83 3.8 2.7 17.45 1.5 1.9
Ser 2.54 11.1 11.9 3.83 5.3 6.5 5.83 −0.9 3.3
Asn 1.29 7.9 9.6 2.85 12.0 10.6 5.10 6.4 6.8
Hit 5.02 4.7 2.1 13.18 2.3 3.2 26.62 0.9 2.1
Arg 0.09 9.6 5.8 0.36 3.1 4.1 0.78 −2.5 4.6
Lys 0.35 4.8 8.5 1.69 0.1 4.1 3.91 −0.8 2.1
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Comparison of amino acid analysis with AccQ-Tag
The data obtained by the AccQ-Tag method were unsatisfac-
tory for most amino acids. Throughout the chromatogram, 
large numbers of compounds in the urine were found to 
co-elute with the free amino acids. In addition, co-elution 
amongst free amino acids was also observed, such as Ser, 
Asn and Gln. Manual processing on all the data had enabled 
confident quantification of four amino acids, namely Phe, 
Trp, Leu and Ile. We subsequently calculated the TEM for 
these four amino acids and found the TEM was typically 
<26 % (Ile 15.7 %, Phe 17.2 %, Leu 17.7 % and Trp 25.6 %).
Bland–Altman plots that assess the agreement between 
two different measurement techniques were plotted for 
Phe, Try, Leu and Ile using both the absolute measured 
value (µM) and adjusted for urinary creatinine (µM/mM). 
The mean difference between two measurements and limits 
of agreement within ±1.96 standard deviation (SD) of the 
differences are included as references. As the results were 
similar for both the mean absolute measured values and the 
adjusted for urinary creatinine values, we only presented 
the results based on the adjusted for urinary creatinine 
(Fig. 5). In general, we found all four amino acids showed 
good agreement between the two methods. The mean 
difference to the mean concentration for all measurements 
between the two methods was the lowest for Ile (2.9 %), 
followed by Phe (11.4 %), Trp (12.1 %) and the highest 
for Leu (16.1 %). Moreover, individual measurement dif-
ferences of the four amino acids scatter randomly with no 
apparent systematic error being detected. We also plotted 
the Bland–Altman plots for the remaining 14 amino acids 
and found these amino acids showed lower concentration 
values for UPLC-qTOF-MS method. We found the mean 
differences were proportionately more negative with higher 
concentration of the analyte indicating some systematic 
errors. This is in compliance with our observations where 
co-elution was observed in AccQ-Tag method. An exem-
plar of this is shown using Asn, Fig. 5e.
As the majority of the free amino acids were not validated 
using the AccQ-Tag method, we then validated our method 
using a NIST certified amino acids standard containing 17 
amino acids at 2.5 mM each. This NIST standard contains 
all the amino acid of our interest except Trp, Gln and Asn. 
However, as the Bland–Altman plots show good agreement 
between AccQ-Tag and UPLC-qTOF-MS for Trp, we deemed 
the results of our UPLC-qTOF-MS were acceptable for 
Trp. However, we were unable to further validate the results 
for Gln and Asn. The remaining 15 amino acids (Ala, Arg, 
Table 6  Application of UPLC-qTOF-MS for the analysis of 646 human urine samples, analysed over a total of 5 batches
* The actual urinary concentration for each amino acid is 15 times of the reported measured concentration due to the 15-fold dilution of the urine 
sample during sample preparation






















Phe 2.56 3.7 3.3 5.32 3.0 2.0 9.69 0.2 1.7
Trp 4.25 3.0 4.0 7.05 3.2 2.9 11.57 2.1 2.5
Leu 1.84 0.8 3.6 4.66 3.0 3.5 9.17 1.5 3.1
Ile 0.82 2.3 5.5 2.32 7.5 5.0 4.44 0.8 4.4
Met 0.32 5.0 6.8 0.84 −0.3 4.4 1.68 −3.8 3.5
Val 2.05 7.4 7.2 4.83 4.7 4.0 9.42 3.4 2.4
Pro 0.38 3.1 6.1 0.90 −0.6 8.0 1.77 −2.0 5.1
Tyr 4.55 3.4 7.2 11.16 0.1 5.5 21.58 −3.6 4.5
Ala 8.54 −1.2 2.6 22.38 1.1 2.9 45.10 1.0 2.6
Thr 3.05 0.7 4.4 5.86 2.2 3.2 10.07 −1.6 3.1
Gly 18.81 2.8 2.7 27.62 4.6 3.7 39.82 −0.2 3.1
Glu 0.12 9.6 8.8 0.41 7.5 5.5 0.84 1.3 4.9
Gln 6.53 4.2 2.5 10.72 3.9 2.5 17.33 1.6 2.6
Ser 2.36 4.7 6.4 3.74 3.8 6.1 5.76 −1.5 4.2
Asn 1.21 4.0 6.5 2.63 4.4 7.1 4.90 2.9 4.8
Hit 4.98 5.0 2.3 13.19 2.7 2.5 26.42 0.3 2.4
Arg 0.09 8.9 5.3 0.36 1.6 3.8 0.79 −1.0 3.3
Lys 0.34 3.5 6.5 1.66 −0.9 4.1 3.85 −1.8 4.2
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Glu, Gly, Hit, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Tyr and 
Val) were analysed by UPLC-qTOF-MS method after serial 
dilution with water to give concentrations of 0.8 and 5 µM. 
These concentrations were chosen to allow the majority of 
amino acids to have at least two concentration points that fall 
within our standard calibration curve for each compound. In 
Fig. 5  Bland–Altman plots for amino acids showing agreement between UPLC-MS and AccQ-Tag methods for a Phe, b Trp, c Ile, d Leu, and e 
Asn
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addition, we also extended the calibration curves to 14-point 
calibration curve for each amino acid to accommodate the 
compounds that were above or below the initial seven-point 
calibration curve. Each NIST standard (0.8 and 5 µM) was 
analysed in replicates of five and the results are presented in 
Table 4. The majority of the amino acids show good accuracy 
and precision (generally <5 %), again were well within the 
required FDA guidelines for developing an analytical method 
for the analysis of biofluids. Based on these results, we found 
the dynamic range of our calibration curve could potentially 
be extended considerably up to three orders magnitude (up to 
2400-fold) for six of the amino acids. The dynamic range for 
Tyr, Pro, Thr, Glu, Ser, Lys and Arg was extended to 300-fold 
whilst for Gly and Hit, they were extended to 600-fold. The 
linearity for this extended dynamic range remains good with 
r2 ≥ 0.993 (Table 4). This extended dynamic range is similar 
to that reported for triple quadrupole methods of 2–3 orders 
of magnitude (Guo et al. 2013).
Clinical application
Having validated our UPLC-qTOF-MS method using 
the NIST standard and to show utility of this method in 
real samples, we analysed 87 urine samples randomly 
selected from the OmniHeart study. We were able to 
detect and quantify all 18 free amino acids in all urine 
samples. The levels of concentration detected were gen-
erally within the ranges of the calibration curve used here 
in this paper. In our experimental design, we included 
the analysis of a QC pooled sample in every 12th sam-
ple and included three replicates of QCL, QCM and QCH 
as well as a seven-point calibration standards. Using 
this design, we were able to complete the analysis of 
87 samples within 2 days. This is quicker than existing 
methods such as the AccQ-Tag and ninhydrin methods 
where these methods typically required 2–3 h analysis 
time per sample. We found the accuracy and precision of 
the QCL, QCM and QCH fulfilled current FDA require-
ments (Table 5). We then applied this method to quantify 
the remaining 559 samples. These were analysed over 4 
batches, with some batches containing up to 192 samples. 
Each batch was analysed without cleaning the instru-
ment. A total of 45 QCL, QCM and QCH samples were 
acquired. We use a 25 mDa chromatogram mass window 
to extract the EICs to mitigate any effects of mass cali-
bration drift in the instrument over long (up to 90 h for 
some batches) chromatographic runs. These QC samples 
were used to evaluate the inter-batch precision and accu-
racy of our method. We found the inter-batch accuracy 
and precision was typically <10 % for QCL and QCM 
and <5 % for QCH (Table 6).
Conclusion
A HILIC-based chromatographic method was adapted to a 
UPLC-qTOF platform for simultaneous quantification of 
18 free amino acids in human urine samples. The UPLC-
qTOF-MS method involves a facile sample preparation step 
which involves dilution with acetonitrile without the need 
of any derivatization. The method has been successfully 
applied for the analysis of human urine samples obtained 
from human volunteers with good accuracy and precision 
that passed all the FDA requirements. This demonstrates 
our approach a potential valuable tool to provide high-qual-
ity targeted analysis for the characterization of free amino 
acids in the urine samples. Moreover, the UPLC-qTOF-MS 
method also offers an added advantage whereby additional 
untargeted data collected during the analysis may be fur-
ther analysed to extract useful information.
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